Expand GRCE Menu
GRCE MENU

GRCE Latest Press Releases

-- August 13, 2026 --

Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update Globe Newswire 8:00 AM

-- August 4, 2026 --

Grace Therapeutics Announces $10 Million Private Placement Globe Newswire 9:00 PM

-- July 28, 2026 --

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration Globe Newswire 7:00 AM

-- June 18, 2026 --

Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update Globe Newswire 8:00 AM

-- June 8, 2026 --

GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm PRNewswire 12:51 PM

-- June 3, 2026 --

GRCE INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Grace Therapeutics, Inc. Globe Newswire 3:54 PM

-- May 27, 2026 --

GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire 11:33 AM

-- May 19, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE Globe Newswire 5:46 PM

-- May 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE PRNewswire 11:01 PM

-- April 23, 2026 --

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 Globe Newswire 1:13 PM

-- April 14, 2026 --

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 Globe Newswire 8:00 AM

-- March 19, 2026 --

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes